Volume 19, Number 12—December 2013
Evaluation of 3 Electronic Methods Used to Detect Influenza Diagnoses during 2009 Pandemic
Highlight and copy the desired format.
|EID||Mulpuru S, Smith T, Lawrence N, Wilson K, Forster A. Evaluation of 3 Electronic Methods Used to Detect Influenza Diagnoses during 2009 Pandemic. Emerg Infect Dis. 2013;19(12):2062-2063. https://dx.doi.org/10.3201/eid1912.131012|
|AMA||Mulpuru S, Smith T, Lawrence N, et al. Evaluation of 3 Electronic Methods Used to Detect Influenza Diagnoses during 2009 Pandemic. Emerging Infectious Diseases. 2013;19(12):2062-2063. doi:10.3201/eid1912.131012.|
|APA||Mulpuru, S., Smith, T., Lawrence, N., Wilson, K., & Forster, A. (2013). Evaluation of 3 Electronic Methods Used to Detect Influenza Diagnoses during 2009 Pandemic. Emerging Infectious Diseases, 19(12), 2062-2063. https://dx.doi.org/10.3201/eid1912.131012.|
To the Editor: Conducting influenza surveillance in hospitals is imperative to detect outbreaks, inform infection control policy, and allocate resources (1). Hospital administrative data could be harnessed for this purpose (2,3) but are not currently used for infection surveillance because of data lag times. Influenza cases could be identified by using International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), codes within the discharge abstract, pharmacy, and microbiology laboratory information systems. Although these approaches are assumed to accurately identify influenza cases, this assumption has not been widely tested, especially during a pandemic. In this retrospective cohort study, we aimed to identify and evaluate 3 electronic methods of influenza case detection during 1 peak of influenza A(H1N1)pdm09.
With ethics board approval, we used the Ottawa Hospital Data Warehouse (OHDW) (Ottawa, ON, Canada) to identify 398 adult inpatients at the Ottawa Hospital during October–December 2009 who had cardiac, infectious, or respiratory disease diagnoses (ICD-10-CM codes: all J codes, A15–19, A37, A40, A41, A49, I26, I28, I50, I51.4, R57). OHDW is a relational database containing pharmacy, laboratory, and discharge diagnosis information for inpatients at Ottawa Hospital. We detected influenza in the following ways: influenza diagnosis in the discharge abstract database (DAD) (ICD-10-CM codes J09–J11); prescription for an antiviral drug (oseltamivir, zanamivir) in the pharmacy system; and a positive laboratory test during the hospital encounter (without specifying test type or specimen) in the laboratory system.
We assessed these case definitions against a criterion standard of influenza diagnosis on the hospital chart, determined by a physician reviewer blinded to the electronic values for the case definitions. We constructed 2 × 2 contingency tables for each classification method and calculated sensitivity, specificity, positive predictive value (PPV), and likelihood ratios using standard equations.
Influenza prevalence in this cohort was 13.6% (54/398) by our criterion standard. The proportion of male and female patients was equal, with a median age of 69 years (interquartile range 53–81 years). Median length of hospital stay was 6 days (interquartile range 1–12 days). A total of 77 (19.3%) patients were admitted to the intensive care unit, and 51 (12.8%) patients died in hospital. Two (0.5%) patients died with a primary diagnosis of influenza. The Table shows the performance characteristics of each influenza classification method against the criterion standard. The DAD-based influenza diagnosis algorithm was most accurate, with sensitivity of 90.7% (95% CI 79.7%–96.9%), specificity of 96.5% (95% CI 94%–98.2%), and PPV of 80.3%.
Our results demonstrate adequate correlation between ICD-10-CM coding for influenza in adults during a 3-month peak of the pandemic season within a single institution. Coding or interpretative errors were the probable cause of the 10% false-negative and 3% false-positive rates of ICD-10 coding for influenza on the DAD.
Classifying influenza by antiviral prescription was sensitive but less specific than clinical diagnosis. This finding could be explained by empiric antiviral prescriptions for infectious respiratory symptoms being written before confirmatory testing (4). Influenza classification by positive laboratory tests was specific but less sensitive in this analysis, probably because of nonuniform laboratory testing among inpatients from lack of specific criteria to guide testing and lack of testing in those with less severe illness. Not all patients who have influenza are tested for it, and these diagnoses would be classed as false negatives, influencing the sensitivity downward. Furthermore, laboratory testing would be likely to miss patients with influenza-triggered exacerbations of congestive heart failure and chronic obstructive pulmonary disease (5), which would underestimate influenza cases.
Our study correlated ICD-10-CM–specific codes for influenza in hospitalized adults during 1 peak of the 2009 influenza pandemic. A previous study in the United States in 2006 evaluated ICD-9-CM admission and discharge influenza codes in hospitalized children (6). The authors found that of 715 laboratory-confirmed influenza cases, ICD-9-CM codes were only 65% sensitive, suggesting that use of these codes for surveillance would underestimate influenza hospitalizations by 35% (6). This work was undertaken in 3 consecutive nonpandemic influenza seasons during 2001–2004.
Our findings must be generalized with caution because our study evaluated ICD-10-CM coding accuracy over 3 months of a pandemic influenza season in adults at 1 academic hospital. With lower influenza prevalence, the PPV would drop, suggesting that the coded diagnosis would overestimate influenza hospitalizations. Furthermore, sensitivity and specificity of codes might not be static measures because the diagnosis of influenza on the chart might be influenced by the prevalence of influenza in communities (7).
Given these limitations, further work is needed to fully validate ICD-10 codes for influenza during seasons of low prevalence and in other populations including children. Despite this, our results have implications for future research using administrative data to develop timely surveillance systems, track costs, and monitor resource use.
We thank the Ontario Thoracic Society and sponsors of the Cameron C. Gray Fellowship award.
S.M. is supported by a Cameron C. Gray Fellowship award from the Ontario Thoracic Society.
- Public Health Agency of Canada. FluWatch Program, Canada. 2013 June 21 [cited 2013 Jul 4]. http://www.phac-aspc.gc.ca/fluwatch/
- Dailey L, Wallstrom GL, Watkins RE, Wagner MM, Riley TV, Plant AJ. The potential of hospital data sources for influenza surveillance. Advances in Disease Surveillance. 2007;2:196.
- Espino JU, Wagner MM. Accuracy of ICD-9–coded chief complaints and diagnoses for the detection of acute respiratory illness. Proc AMIA Symp. 2001;•••:164–8 .
- Aoki FY, Allen UD, Stiver HG, Evans GA. The use of antiviral drugs for influenza: guidance for practitioners 2012/2013. Can J Infect Dis Med Microbiol. 2012;23:e79–92.
- Yap FHY, Ho P-L, Lam K-F, Chan PKS, Cheng Y-H, Peiris JSM. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol. 2004;73:617–23.
- Keren R, Wheeler A, Coffin SE, Zaoutis T, Hodinka R, Heydon K. ICD-9 codes for identifying influenza hospitalizations in children. Emerg Infect Dis. 2006;12:1603–4.
- Moore K, Black J, Rowe S, Franklin L. Syndromic surveillance for influenza in two hospital emergency departments. Relationships between ICD-10 codes and notified cases, before and during a pandemic. BMC Public Health. 2011;11:338.
- Table. Performance characteristics of electronic influenza classification methods compared to criterion standard chart review, Ottawa Hospital, Ottawa, Ontario, Canada, October–December 2009
Please use the form below to submit correspondence to the authors or contact them at the following address:
Sunita Mulpuru, 1053 Carling Ave, Box 684, Admin Services Bldg, 1st Floor, Room 1019, Ottawa, ON K1Y 4E9, CanadaSunita Mulpuru, 1053 Carling Ave, Box 684, Admin Services Bldg, 1st Floor, Room 1019, Ottawa, ON K1Y 4E9, Canada
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: November 20, 2013
- Page last updated: November 20, 2013
- Page last reviewed: November 20, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)